Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Y Wang, X Wu, Z Ren, Y Li, W Zou, J Chen… - Drug Resistance …, 2023 - Elsevier
Abstract Development of resistance to chemotherapy in cancer continues to be a major
challenge in cancer management. Ferroptosis, a unique type of cell death, is mechanistically …
challenge in cancer management. Ferroptosis, a unique type of cell death, is mechanistically …
[HTML][HTML] Non-coding RNAs and ferroptosis: potential implications for cancer therapy
Ferroptosis is a recently defined form of regulated cell death, which is biochemically and
morphologically distinct from traditional forms of programmed cell death such as apoptosis …
morphologically distinct from traditional forms of programmed cell death such as apoptosis …
[HTML][HTML] Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4 …
R Qi, Y Bai, K Li, N Liu, Y Xu, E Dal, Y Wang… - Drug Resistance …, 2023 - Elsevier
Background Pancreatic cancer continues to be one of the world's most lethal cancers.
Chemotherapy resistance in patients with advanced pancreatic cancer often accompany …
Chemotherapy resistance in patients with advanced pancreatic cancer often accompany …
[HTML][HTML] ACSL3 and ACSL4, distinct roles in ferroptosis and cancers
Y Yang, T Zhu, X Wang, F Xiong, Z Hu, X Qiao, X Yuan… - Cancers, 2022 - mdpi.com
Simple Summary The dysregulation of ACSL3 and ACSL4, which belong to the long-chain
fatty acyl CoA synthetase family (ACSLs), affects the behavior of various cancer cells. This …
fatty acyl CoA synthetase family (ACSLs), affects the behavior of various cancer cells. This …
[HTML][HTML] miR-124-3p delivered by exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells inhibits ferroptosis to attenuate ischemia …
L Wu, X Tian, H Zuo, W Zheng, X Li, M Yuan… - Journal of …, 2022 - Springer
Background Steatotic livers tolerate ischemia–reperfusion injury (IRI) poorly, increasing the
risk of organ dysfunction. Ferroptosis is considered the initiating factor of organ IRI. Heme …
risk of organ dysfunction. Ferroptosis is considered the initiating factor of organ IRI. Heme …
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
Hepatocellular carcinoma is the most prevalent form of primary liver cancer with a
multifactorial aetiology comprising genetic, environmental, and behavioural factors. Evading …
multifactorial aetiology comprising genetic, environmental, and behavioural factors. Evading …
Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer
K Zeng, W Li, Y Wang, Z Zhang, L Zhang… - Advanced …, 2023 - Wiley Online Library
Oxaliplatin is a widely used chemotherapy drug for patients with advanced colorectal cancer
(CRC); however, frequent drug resistance limits its therapeutic efficacy in patients. Here, this …
(CRC); however, frequent drug resistance limits its therapeutic efficacy in patients. Here, this …
[HTML][HTML] A graphical journey through iron metabolism, microRNAs, and hypoxia in ferroptosis
DC Fuhrmann, B Brüne - Redox biology, 2022 - Elsevier
Ferroptosis is an iron-dependent form of cell death, which is triggered by disturbed
membrane integrity due to an overproduction of lipid peroxides. Induction of ferroptosis …
membrane integrity due to an overproduction of lipid peroxides. Induction of ferroptosis …
[HTML][HTML] MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis
L Shi, Z Song, Y Li, J Huang, F Zhao, Y Luo… - American Journal of …, 2023 - Elsevier
Ischemia/reperfusion injury (IRI) is prone to occur after kidney transplantation, leading to
delayed graft function (DGF). MicroRNAs play a crucial role in the pathogenesis of …
delayed graft function (DGF). MicroRNAs play a crucial role in the pathogenesis of …
Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
A potential reason for the failure of tumor therapies is treatment resistance. Resistance to
chemotherapy, radiotherapy, and immunotherapy continues to be a major obstacle in clinic …
chemotherapy, radiotherapy, and immunotherapy continues to be a major obstacle in clinic …